David Argue

Dr. Argue is a Managing Director with Secretariat Economists based in Washington, DC. He has analyzed the competition and performed damages analyses in various healthcare markets for government merger reviews and private antitrust litigation. He has also taught MBA-level courses in the economics of healthcare at the Carey Business School of Johns Hopkins University and authored several articles and presentations on healthcare competition matters. Among the healthcare areas in which Dr. Argue has consulting experience are hospitals, physician practices, ambulatory surgery centers, health insurance, prostheses, and pharmaceuticals. Dr. Argue’s recent experience includes trial testimony in FTC v. Otto Bock HealthCare. He also testified at trial in Saint Alphonsus et al. and FTC v. St. Luke’s Health System and before the Utah legislature about healthcare markets in Utah.

Dr. Argue has performed competition and damages analyses in other industries as well, including cement, propane distribution, grocery stores, copper production, funeral homes, pesticides, telecommunications, newspapers, steel and industrial controls. He has also conducted damages analyses in several employment-related matters.

In addition, he has expertise in environmental matters including commercial damages estimates in the Exxon Valdez oil spill, assessment of natural resource damage claims, and class certification in environmental litigation. Dr. Argue authored an article entitled “The Deepwater Horizon Oil Spill and Seafood Prices” that appeared in the November 2010 issue of Environmental Law Reporter. Previously he co-authored a book entitled The Economics of a Disaster: The Exxon Valdez Oil Spill.